2nd Gene Therapy for Blood Disorders

Kongressthemen
There's currently a lot of exciting news circulating about the progress of genetic therapies targeting blood disorders.

As more and more promising results emerge from various clinical 3 trials, it's essential that this industry comes together to share knowledge, optimize trial design and discuss strategies for commercial launch.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/698778-3?pid=4832

Speakers: Gabriela Denning, Vice President, Research and Development, Expression Therapeutics, Clark Paramore, Head of Value Demonstration, Vice President HEOR, bluebird bio, and more.

https://go.evvnt.com/698778-2?pid=4832

Frau Ellie Saunders